Position in ABBV
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$7,658,160
+$1,076,913 QoQ
Shares Held
30,433
+0.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.98%
of 13F equity value
Holder Rank
#1,052
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026West Branch Capital LLC holds $28,624,658 across 10 Drug Manufacturers - General names. ABBV ranks #3 (26.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,703 | $10,438,640 | |
| 2 | JNJ |
Johnson & Johnson
|
33,416 | $8,486,661 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
30,433 | $7,658,160 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,301 | $1,066,678 | |
| 5 | AMGN |
Amgen Inc
|
1,167 | $422,594 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,186 | $276,179 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,350 | $135,407 | |
| 8 | PFE |
Pfizer Inc
|
4,359 | $104,964 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,658,160 | 30,433 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $6,581,247 | 30,260 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $6,875,949 | 30,093 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $6,939,485 | 29,971 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $5,503,633 | 29,650 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $6,153,183 | 29,368 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $5,107,631 | 28,743 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $5,849,555 | 29,621 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $5,037,370 | 29,369 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $5,398,172 | 29,644 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $4,531,942 | 29,244 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $4,342,266 | 29,131 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $3,902,723 | 28,967 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $4,595,752 | 28,837 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $4,660,670 | 28,839 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $3,870,750 | 28,841 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $4,422,188 | 28,873 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $4,684,006 | 28,894 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $3,944,202 | 29,130 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $3,142,468 | 29,132 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,025,172 | 26,857 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $2,844,346 | 26,283 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,913,837 | 27,194 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,387,090 | 27,253 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,650,270 | 26,994 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $2,022,463 | 26,545 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||